Aurobindo Pharma’s CuraTeQ Biologics to invest around Rs. 300 crore for capacity expansion | The Financial Express

Aurobindo Pharma’s CuraTeQ Biologics to invest around Rs. 300 crore for capacity expansion

Further, the board also approved entering into contract manufacturing operations (CMO) for biologicals for effective utilisation of capacities.

Aurobindo Pharma’s CuraTeQ Biologics to invest around Rs. 300 crore for capacity expansion
Auro Vaccines is engaged in the business of developing and manufacturing vaccines biologicals. (File)

Aurobindo Pharma on Thursday announced that its CuraTeQ Biologics is planning to invest around Rs 300 crore in capacity expansion of biologics manufacturing facilities.

According to a report by news agency PTI, the board of directors of CuraTeQ Biologics at its meeting held on Thursday, approved the expansion of its operations by establishing another mammalian cell culture manufacturing facility of higher capacity to cater to the future requirements, Aurobindo Pharma said in a regulatory filing.

“The capital expenditure for ramping up capacities is estimated to be around Rs 300 crore,” it said, adding that the facility is likely to be fully operational by FY26.

Further, the board also approved entering into contract manufacturing operations (CMO) for biologicals for effective utilisation of capacities.

ALSO READ | USFDA issues one observation to Aurobindo Pharma subsidiary’s plant

This would augment the business prospects in this area as the global biologics contract manufacturing demand is growing at 8-10 per cent and CuraTeQ will actively seek customers in CMO area, it added as quoted by PTI.

The company further said the board of its another wholly-owned subsidiary, Auro Vaccines Pvt Ltd, has also approved exploring possibilities to offer contract manufacturing services to global vaccine developers to effectively utilise its existing manufacturing capacity.

Auro Vaccines is engaged in the business of developing and manufacturing vaccines biologicals.

(With inputs from PTI)

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.